8-K: Lantern Pharma Inc. Discusses Q3 2024 Financial and Operating Results in Conference Call and Webinar
Quarterly Results Discussion
Lantern Pharma Inc. held a conference call and live webinar on November 7, 2024, to discuss their financial and operating results for the third quarter ended September 30, 2024.
Summary
- Lantern Pharma Inc. hosted a conference call and live webinar on November 7, 2024, to discuss their financial and operating results for the third quarter of 2024.
- The company used a presentation during the call, which is included as an exhibit to the report.
- The discussion focused on the financial and operational performance for the quarter ending September 30, 2024.
Sentiment
Score: 5
Explanation: The document is a factual report of a conference call and webinar, with no clear positive or negative sentiment.
Stakeholder Impact
- Shareholders were informed about the company's Q3 2024 performance through the conference call and webinar.
Key Dates
| Date | Description |
|---|---|
| 2024-09-30 | End of the third quarter for which financial and operating results are discussed. |
| 2024-11-07 | Date of the conference call and live webinar to discuss Q3 2024 results. |
Keywords
financial results, operating results, conference call, webinar, Q3 2024, Lantern Pharma
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.